Organon announced today that it agreed to sell its Jada intrauterine vacuum system to Laborie Medical Technologies for up to $465 million.

Please provide your email address to receive an email when new articles are posted on . Levonorgestrel-releasing intrauterine system users vs. nonusers had an increased risk for breast cancer. Breast ...

The study was a multicentre, double-blind, randomised, placebo-controlled trial of mepivacaine (10 mL of 20 mg/mL) vs placebo (0.9 mg/mL sodium chloride) instilled into the uterus 2 minutes before IUD ...